Soluble and Endogenous Secretory Receptors for Advanced Glycation End Products in Threatened Preterm Labor and Preterm Premature Rupture of Fetal Membranes

Biomed Res Int. 2015:2015:568042. doi: 10.1155/2015/568042. Epub 2015 Aug 27.

Abstract

The aim of the study was to compare sRAGE and esRAGE plasma levels in pregnant women with (A) threatened premature labor (n = 41), (B) preterm premature rupture of membranes (n = 49), and (C) preterm rupture of membranes at term (n = 48). The relationship between these and classic intrauterine infection markers and the latent time from symptoms up to delivery depending on RAGE's concentration were investigated. In groups A and B, a positive correlation was found between plasma sRAGE and latent time (r = 0,422; p = 0,001; r = 0,413, p = 0,004, resp.). High prognostic values were found in both groups for plasma sRAGE concentration and the latent time from symptoms up to delivery. Groups B and C presented higher levels of esRAGE than group A (526,315 ± 129,453 pg/mL and 576,212 ± 136,237 pg/mL versus 485,918 ± 133,127 pg/mL, p< 0,05). The conclusion is that sRAGE concentration can be a favorable prognostic factor in the presence of symptoms of threatened premature labor. Higher esRAGE plasma level in case of the rupture of membranes in mature and premature pregnancy suggests its participation in fetal membranes destruction.

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Fetal Membranes, Premature Rupture / blood*
  • Fetal Membranes, Premature Rupture / diagnosis
  • Fetal Membranes, Premature Rupture / epidemiology
  • Humans
  • Obstetric Labor, Premature / blood*
  • Obstetric Labor, Premature / diagnosis
  • Obstetric Labor, Premature / epidemiology
  • Pregnancy
  • Receptor for Advanced Glycation End Products / blood*
  • Sensitivity and Specificity
  • Young Adult

Substances

  • AGER protein, human
  • Receptor for Advanced Glycation End Products